COFCO Biotechnology Co., Ltd. (SHE:000930)
China · Delayed Price · Currency is CNY 6.80
+0.06 (0.89%)
Apr 10, 2026, 3:04 PM CST
COFCO Biotechnology Revenue
COFCO Biotechnology had revenue of 4.45B CNY in the quarter ending September 30, 2025, a decrease of -14.65%. This brings the company's revenue in the last twelve months to 18.19B, down -12.47% year-over-year. In the year 2024, COFCO Biotechnology had annual revenue of 20.05B, down -1.60%.
Revenue (ttm)
18.19B
Revenue Growth
-12.47%
P/S Ratio
0.69
Revenue / Employee
3.46M
Employees
5,261
Market Cap
12.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.05B | -325.59M | -1.60% |
| Dec 31, 2023 | 20.38B | 460.90M | 2.31% |
| Jan 1, 2023 | 19.92B | -3.64B | -15.46% |
| Jan 1, 2022 | 23.56B | 3.65B | 18.33% |
| Dec 31, 2020 | 19.91B | 437.40M | 2.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Transfar Zhilian | 26.18B |
| Qingdao Gon Technology | 21.25B |
| Explosive | 9.83B |
| Jihua Group Corporation | 7.16B |
| Shandong Dawn Polymer | 6.06B |
| Zhejiang Runtu | 5.79B |
| Yangzhou Tinfulong Group | 3.62B |
| Jiangsu Ruitai New Energy Materials | 1.98B |